Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection.

Source:http://linkedlifedata.com/resource/pubmed/id/11152225

Transplantation 2000 Dec 15 70 11 1616-24

Download in:

View as

General Info

PMID
11152225